Kodiak Sciences (KOD) Total Current Liabilities (2017 - 2026)
Kodiak Sciences (KOD) reported Total Current Liabilities of $49.6 million for Q1 2026, up 60.56% on a YoY basis from $30.9 million in Q1 2025, and up 8.87% quarter-over-quarter from $45.5 million in Q4 2025.
Kodiak Sciences (KOD) Total Current Liabilities (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Total Current Liabilities for 10 years, with the latest figure at $49.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 60.56% year-over-year to $49.6 million; the trailing twelve-month figure through Mar 2026 stood at $49.6 million (up 60.56% YoY), and the FY2025 full-year result was $45.5 million, up 78.05% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $49.6 million, up from $45.5 million in the prior quarter.
- The five-year high for Total Current Liabilities was $76.3 million in Q1 2022, with the low at $21.2 million in Q2 2024.
- Historically, Total Current Liabilities has averaged $47.9 million across 5 years, with a median of $45.5 million in 2025.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 117.74% — and 2024, when it tumbled 71.44%.
- Kodiak Sciences' Total Current Liabilities stood at $52.5 million in 2022, then decreased by 20.51% to $41.7 million in 2023, then sank by 38.72% to $25.6 million in 2024, then soared by 78.05% to $45.5 million in 2025, then rose by 8.87% to $49.6 million in 2026.
- The last three Total Current Liabilities figures came in at $49.6 million (Q1 2026), $45.5 million (Q4 2025), and $42.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 72.86 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 49.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.57 Mn |
| Dec 31, 2025 | 45.53 Mn |
| Sep 30, 2025 | 42.43 Mn |
| Jun 30, 2025 | 31.01 Mn |
| Mar 31, 2025 | 30.88 Mn |
| Dec 31, 2024 | 25.57 Mn |
| Sep 30, 2024 | 24.06 Mn |
| Jun 30, 2024 | 21.20 Mn |
| Mar 31, 2024 | 24.86 Mn |
| Dec 31, 2023 | 41.73 Mn |
| Sep 30, 2023 | 70.77 Mn |
| Jun 30, 2023 | 74.24 Mn |
| Mar 31, 2023 | 68.94 Mn |
| Dec 31, 2022 | 52.50 Mn |
| Sep 30, 2022 | 65.60 Mn |
| Jun 30, 2022 | 69.83 Mn |
| Mar 31, 2022 | 76.33 Mn |
| Dec 31, 2021 | 64.68 Mn |
| Sep 30, 2021 | 54.40 Mn |
| Jun 30, 2021 | 41.02 Mn |